Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Repligen Corp RGEN

Technology Scientific & Technical Instruments
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial... see more

Recent & Breaking News (NDAQ:RGEN)

15 Biggest Mid-Day Losers For Tuesday

Benzinga.com  September 26, 2017

Repligen Announces Analyst Day and Webcast

GlobeNewswire September 15, 2017

Repligen to Present at Baird’s 2017 Global Healthcare Conference

GlobeNewswire August 30, 2017

Repligen Reports Second Quarter 2017 Financial Results

GlobeNewswire August 3, 2017

Investor Network: Repligen Corporation to Host Earnings Call

Accesswire August 3, 2017

Repligen to Report Second Quarter 2017 Financial Results

GlobeNewswire July 27, 2017

Repligen Corporation Prices Public Offering of Shares of Common Stock

GlobeNewswire June 27, 2017

Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock

GlobeNewswire June 26, 2017

A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of Fed Speakers, Economic Data

Benzinga.com  June 23, 2017

Repligen Corporation and Spectrum, Inc. to Join Forces

GlobeNewswire June 23, 2017

Repligen to Present at Jefferies’ 2017 Global Annual Healthcare Conference

GlobeNewswire May 31, 2017

Repligen to Participate in 14th Annual Craig-Hallum Institutional Investor Conference

GlobeNewswire May 24, 2017

Repligen to Present at Bank of America Merrill Lynch 2017 Healthcare Conference

GlobeNewswire May 9, 2017

Repligen Reports First Quarter 2017 Financial Results

GlobeNewswire May 4, 2017

Investor Network: Repligen Corporation to Host Earnings Call

Accesswire May 4, 2017

Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017

GlobeNewswire February 22, 2017

Repligen To Report Fourth Quarter and Full Year 2016 Financial Results, Provides Financial Guidance for 2017

GlobeNewswire February 16, 2017

Repligen to Present at 35th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 4, 2017

Repligen to Participate in Stephens Inc. Fall Investment Conference 2016

GlobeNewswire November 7, 2016

Repligen Reports Third Quarter 2016 Financial Results

GlobeNewswire November 3, 2016